StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
82
This month
2
This year
10
Publishing Date
2024 - 03 - 12
2
2023 - 10 - 31
2
2023 - 09 - 26
1
2023 - 09 - 25
1
2023 - 09 - 15
1
2023 - 09 - 11
1
2023 - 08 - 30
1
2023 - 08 - 28
1
2023 - 08 - 09
2
2023 - 07 - 25
1
2023 - 06 - 23
1
2023 - 05 - 24
1
2023 - 05 - 10
2
2023 - 05 - 09
1
2023 - 04 - 30
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 13
1
2023 - 03 - 09
1
2023 - 03 - 08
1
2023 - 03 - 01
2
2023 - 02 - 07
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2023 - 01 - 25
2
2023 - 01 - 22
1
2022 - 12 - 15
1
2022 - 11 - 15
1
2022 - 09 - 15
1
2022 - 09 - 01
1
2022 - 08 - 02
1
2022 - 07 - 21
1
2022 - 07 - 12
1
2022 - 07 - 10
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 05 - 18
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 05
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 24
2
2022 - 01 - 11
1
2021 - 12 - 21
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 10 - 07
1
2021 - 09 - 07
1
2021 - 09 - 03
1
2021 - 08 - 03
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 05
1
2021 - 03 - 16
2
2021 - 02 - 18
1
2021 - 01 - 12
1
2021 - 01 - 04
1
Sector
Consumer services
1
Health technology
82
Manufacturing
3
Tags
Alliances
1
Annual needham
1
Annual needham virtual healthcare conference
1
Association
1
Bay
1
Bexotegrast
8
Biotech
1
Biotech-bay
7
Biotechnology
2
Cancer
2
Clearance
1
Clinical-trials-phase-ii
2
Collaboration
1
Conference
15
Congress
1
Designation
3
Drug
1
Enroll
1
Events
4
Fast track designation
2
Fda
3
Fda-approvals
2
Fibrosis
14
Financial
5
Financial results
4
Growth
1
Health
2
Imaging
1
Immunotherapy
2
International
8
Iot
1
J.p. morgan healthcare conference
1
Liver
5
Market
2
Meeting
4
Milestone
1
N/a
60
Needham virtual healthcare conference
1
Offering
3
Ongoing
1
People
3
Phase 1
2
Phase 1b
1
Phase 2
4
Phase 2b
8
Pln-1010
2
Pln-7480
10
Positive
10
Pre-clinical
2
Preclinical
2
Program
2
Respiratory
2
Results
10
Review
2
Sclerosing cholangitis
2
Study
2
Therapeutics
70
Treatment
6
Trial
14
Update
5
Entities
Arrival
2
Astellas pharma inc
1
Calliditas therapeutics ab
1
Cymabay therapeutics inc.
1
Eli lilly and company
1
Johnson & johnson
1
Marker therapeutics, inc.
1
Nektar therapeutics
1
Novartis ag
1
Pliant therapeutics, inc.
82
Sanofi
2
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
82
Nyse
3
Crawled Date
2024 - 03 - 12
2
2023 - 10 - 31
2
2023 - 09 - 26
1
2023 - 09 - 25
1
2023 - 09 - 15
1
2023 - 09 - 11
1
2023 - 08 - 30
1
2023 - 08 - 28
1
2023 - 08 - 09
2
2023 - 07 - 25
1
2023 - 06 - 23
1
2023 - 05 - 24
1
2023 - 05 - 10
2
2023 - 05 - 09
1
2023 - 04 - 30
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 13
1
2023 - 03 - 10
1
2023 - 03 - 09
1
2023 - 03 - 01
2
2023 - 02 - 07
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2023 - 01 - 25
2
2023 - 01 - 22
1
2022 - 12 - 15
1
2022 - 11 - 15
1
2022 - 09 - 15
1
2022 - 09 - 01
1
2022 - 08 - 02
1
2022 - 07 - 21
1
2022 - 07 - 13
1
2022 - 07 - 11
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 05 - 18
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 05
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 24
2
2022 - 01 - 11
1
2021 - 12 - 21
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 10 - 07
1
2021 - 09 - 07
1
2021 - 09 - 03
1
2021 - 08 - 03
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 05
1
2021 - 03 - 16
2
2021 - 02 - 18
1
2021 - 01 - 12
1
2021 - 01 - 04
1
Crawled Time
00:00
4
01:00
2
03:00
1
12:00
12
12:15
3
12:20
6
13:00
8
13:03
2
13:20
4
13:30
2
14:00
6
14:15
1
14:20
2
14:30
1
15:00
2
15:20
1
15:30
1
16:00
1
17:00
1
18:00
1
20:00
6
20:20
2
21:00
7
22:00
5
23:00
1
Source
www.biospace.com
22
www.globenewswire.com
58
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
Previous years
symbols :
PLRX
save search
Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight
Published:
2024-04-03
(Crawled : 22:00)
- prnewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-15.52%
|
O:
1.87%
H:
3.4%
C:
-1.02%
fibrosis
therapeutics
growth
market
Pliant Therapeutics to Participate in Upcoming Investor Events
Published:
2024-04-02
(Crawled : 12:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.51%
|
O:
-0.62%
H:
1.17%
C:
1.17%
therapeutics
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Published:
2024-03-27
(Crawled : 14:30)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-13.79%
|
O:
1.34%
H:
3.63%
C:
1.54%
conference
international
therapeutics
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
Published:
2024-03-12
(Crawled : 17:00)
- biospace.com/
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.1%
|
O:
0.0%
H:
6.88%
C:
4.2%
MRKR
|
$4.25
3.65%
3.52%
15K
|
Consumer Services
|
4.11%
|
O:
-1.2%
H:
4.88%
C:
3.17%
therapeutics
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.1%
|
O:
0.0%
H:
6.88%
C:
4.2%
treatment
fibrosis
bexotegrast
therapeutics
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
Published:
2024-02-27
(Crawled : 21:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-29.17%
|
O:
4.59%
H:
0.0%
C:
-7.67%
update
therapeutics
financial
results
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published:
2024-02-26
(Crawled : 13:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-25.81%
|
O:
-0.3%
H:
4.27%
C:
1.4%
therapeutics
Pliant Therapeutics to Participate in Upcoming Investor Events - February 7, 2024
Published:
2024-02-07
(Crawled : 15:00)
- biospace.com/
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-24.33%
|
O:
0.0%
H:
0.93%
C:
-0.87%
therapeutics
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published:
2024-02-04
(Crawled : 00:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-29.94%
|
O:
-3.62%
H:
0.0%
C:
-5.78%
liver
positive
fibrosis
bexotegrast
trial
therapeutics
Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-03
(Crawled : 13:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-32.13%
|
O:
0.28%
H:
3.44%
C:
0.28%
conference
therapeutics
Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing Cholangitis
Published:
2023-11-13
(Crawled : 22:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-5.14%
|
O:
4.05%
H:
0.6%
C:
-1.5%
meeting
liver
therapeutics
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-14.15%
|
O:
10.0%
H:
2.94%
C:
-11.46%
update
therapeutics
financial
results
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published:
2023-11-08
(Crawled : 13:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-22.31%
|
O:
0.76%
H:
0.0%
C:
-4.93%
therapeutics
Pliant Therapeutics Presentations at the Annual Meeting of the Society for Immunotherapy of Cancer Highlight PLN-101095, A Novel Inhibitor of Integrins αvβ8 and αvβ1
Published:
2023-11-06
(Crawled : 13:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-24.33%
|
O:
-0.12%
H:
1.37%
C:
-3.98%
pln-1010
cancer
immunotherapy
meeting
therapeutics
Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
Published:
2023-10-31
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
3.73%
|
O:
0.94%
H:
2.55%
C:
2.55%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-26.4%
|
O:
-4.18%
H:
0.49%
C:
-0.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
32.11%
|
O:
-2.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.11%
|
O:
0.18%
H:
0.0%
C:
0.0%
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.91%
|
O:
-0.2%
H:
3.45%
C:
1.37%
CALT
|
$17.65
-2.4%
4K
|
Health Technology
|
8.28%
|
O:
-2.27%
H:
2.01%
C:
0.44%
study
market
Pliant Therapeutics Announces Three Presentations at the Annual Meeting of the Society for Immunotherapy of Cancer
Published:
2023-10-31
(Crawled : 20:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.91%
|
O:
-0.2%
H:
3.45%
C:
1.37%
cancer
immunotherapy
meeting
therapeutics
Pliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in an Oral Late-Breaking Presentation at The Liver Meeting® 2023
Published:
2023-10-19
(Crawled : 12:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-10.04%
|
O:
-0.3%
H:
3.26%
C:
2.74%
meeting
liver
presentation
bexotegrast
therapeutics
Pliant Therapeutics Appoints S. Mishima Gerhart as Chief Regulatory Officer
Published:
2023-10-16
(Crawled : 20:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.69%
|
O:
-0.4%
H:
0.0%
C:
0.0%
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-20.84%
|
O:
-0.78%
H:
2.85%
C:
-3.27%
therapeutics
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-54.35%
|
O:
-1.24%
H:
0.0%
C:
0.0%
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.39%
|
O:
7.89%
H:
11.25%
C:
5.98%
liver
positive
fibrosis
bexotegrast
trial
therapeutics
Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
Published:
2023-09-25
(Crawled : 20:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-16.39%
|
O:
7.89%
H:
11.25%
C:
5.98%
trial
therapeutics
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.